Mucolipidosis type IV
A rare genetic disorder affecting lysosomal storage
Classification |
|
---|---|
External resources |
|
Mucolipidosis type IV (ML IV) is a rare lysosomal storage disorder characterized by the accumulation of lipids and mucopolysaccharides in the body's cells. It is an autosomal recessive disorder, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disease.
Genetics[edit | edit source]
ML IV is caused by mutations in the MCOLN1 gene, which encodes the protein mucolipin-1. This protein is involved in the regulation of lysosomal function and membrane trafficking. Mutations in the MCOLN1 gene lead to the dysfunction of lysosomes, resulting in the accumulation of undigested materials within cells.
Clinical Features[edit | edit source]
Individuals with ML IV typically present with developmental delay, intellectual disability, and motor skill impairment. Other common symptoms include:
Diagnosis[edit | edit source]
The diagnosis of ML IV is based on clinical evaluation, laboratory testing, and genetic testing. Laboratory tests may reveal elevated levels of certain lipids and mucopolysaccharides in the blood or urine. Genetic testing can confirm the presence of mutations in the MCOLN1 gene.
Management[edit | edit source]
There is currently no cure for ML IV, and treatment is primarily supportive. Management strategies may include:
- Physical therapy to improve motor skills
- Occupational therapy to assist with daily activities
- Speech therapy to address communication difficulties
- Regular ophthalmologic evaluations to monitor vision
Prognosis[edit | edit source]
The prognosis for individuals with ML IV varies. While some individuals may have a relatively stable course, others may experience progressive neurological decline. Life expectancy can be reduced, but supportive care can improve quality of life.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD